CD274 and head and neck squamous cell carcinoma: Our study provides the first report of PD-L1 expression in circulating blood platelets and introduces them as potentially novel and noN−invasive biomarkers in head and neck squamous cell carcinoma (HNSCC), with yet unexplored implications for checkpoint inhibition therapies.